Inventor

HOFFGAARD FRANZISKA

DE76 patents

Patents

50 patents

US10772915B2Sep 15, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations93

US10709738B2Jul 14, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH3 citations93

US10695374B2Jun 30, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations93

US11072645B2Jul 27, 2021

T cell receptors with improved pairing

IMMATICS BIOTECHNOLOGIES GMBH10 citations85

US11020433B2Jun 1, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH2 citations84

US11951132B2Apr 9, 2024

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11918607B2Mar 5, 2024

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11801264B2Oct 31, 2023

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11779606B2Oct 10, 2023

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11376281B2Jul 5, 2022

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11369636B2Jun 28, 2022

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11357797B2Jun 14, 2022

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11214604B2Jan 4, 2022

Peptides for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH1 citations73

US11208449B2Dec 28, 2021

Peptides for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH3 citations73

US11197892B2Dec 14, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11179418B2Nov 23, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11154576B2Oct 26, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11147838B2Oct 19, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11147839B2Oct 19, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11141437B2Oct 12, 2021

Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11103535B2Aug 31, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11077142B2Aug 3, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11065279B2Jul 20, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11058727B2Jul 13, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11052114B2Jul 6, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11052113B2Jul 6, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11040069B2Jun 22, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11033585B2Jun 15, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11033583B2Jun 15, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11026977B2Jun 8, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11020434B2Jun 1, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11013769B2May 25, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11013766B2May 25, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11013768B2May 25, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10993964B2May 4, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10993962B2May 4, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10905719B2Feb 2, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10905720B2Feb 2, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10898518B2Jan 26, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10898519B2Jan 26, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10894064B2Jan 19, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888586B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888585B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888584B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888583B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888582B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US12060400B2Aug 13, 2024

Peptides for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US11685769B2Jun 27, 2023

Peptides for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10874696B2Dec 29, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10874695B2Dec 29, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

Showing the top 50 of 76 patents by PatentIndex Score.